The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV. (2020)
Attributed to:
Paediatric and adolescent infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jia2.25576
PubMed Identifier: 32869500
Publication URI: http://europepmc.org/abstract/MED/32869500
Type: Journal Article/Review
Volume: 23 Suppl 5
Parent Publication: Journal of the International AIDS Society
Issue: Suppl 5
ISSN: 1758-2652